"We are an eye clinic that specializes in cataracts, glaucoma, medical retina, paediatrics, LASIK, neurological and adult strabismus, corneal, dry eyes and clinical trials We are located in 2 other locations as well: Penrith (02) 4731 1811 295 High Street (Evans Street Entrance), Penrith, 2750 Castle Hill (02) 9634 6364 19/7-9 Barwell Avenue, Castle Hill, 2154"

During the past decade, Marsden Eye Specialists conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 5 clinical trials were completed, i.e. on average, 41.7% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 5 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Marsden Eye Specialists" #1 sponsor was "Hoffmann-La Roche" with 4 trials, followed by "Apellis Pharmaceuticals, Inc." with 3 trials sponsored, "Ionis Pharmaceuticals, Inc." with 2 trials sponsored, "Allergan" with 1 trials sponsored and "Exonate Limited" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Marsden Eye Specialists" #1 collaborator was "Novotech (Australia) Pty Limited" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Marsden Eye Specialists" are "Geographic Atrophy" (7 trials), "Age Related Macular Degeneration" (1 trials), "Age-Related Macular Degeneration" (1 trials), "Diabetic Macular Edema" (1 trials) and "Diabetic Macular Oedema" (1 trials). Many other conditions were trialed in "Marsden Eye Specialists" in a lesser frequency.

Most popular intervention types in "Marsden Eye Specialists" are "Drug" (11 trials), "Other" (5 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Sham Procedure" (3 trials), "Lampalizumab" (2 trials), "No intervention" (2 trials), "APL-2" (1 trials) and "Aflibercept" (1 trials). Other intervention names were less common.

The vast majority of trials in "Marsden Eye Specialists" are 13 trials for "All" genders.

Currently, there are NaN active trials in "Marsden Eye Specialists". undefined are not yet recruiting, 1 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Marsden Eye Specialists, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Marsden Eye Specialists, 1 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".